Kestra Medical Technologies logo

Kestra Medical Technologies(NASDAQ) KMTS

Market Cap$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)+30%
5 YearN/A
1 Year+19%
1 Month+10%
$27.09
-4.24%
-1.20Today
After hours$27.15+$0.06 (+0.22%)
Kestra Medical Technologies last closing stock price
MetricPriceDate
Last closeUSD 28.292026-09-30
Kestra Medical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.9%USD 25.512026-09-23
1 month+9.86%USD 25.752026-08-31
3 month+4.86%USD 26.982026-07-02
Year to date+6.67%USD 26.522025-12-31
1 year+19.07%USD 23.762025-09-30
Since inception+29.53%USD 21.842025-03-06

Kestra Medical Technologies Financials at a Glance

Market Cap

$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$106.73M

Net Income (TTM)

-$149.87M

EPS (TTM)

-$2.67

P/E Ratio

-10.60

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$27.09

Volume

305,554.966

Open

$28.14

Previous Close

$28.29

Daily Range

$26.97 - $29.66

52-Week Range

$17.34 - $30.00

Estimated Earnings Date

Dec 10, 2026

KMTS News

SellAlert-Red.png

What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains

Jonathan PoncianoJun 24, 2026
SellAlert-Red.png

Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares

Jonathan PoncianoMay 15, 2026
BuyAlert-Blue.png

The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock

Seena HassounaApr 3, 2026
Foolcom-Featured.png

Kestra Revenue Jumps 52% in Fiscal Q1

Motley Fool Markets TeamSep 11, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kestra Medical Technologies

Kestra Medical Technologies, Ltd. makes wearable heart monitors that can save lives. These devices check heart rhythms and deliver shocks during emergencies. The company helps patients recover safely from heart-related issues at home.

What Kestra Makes

  • ASSURE WCD: Wearable cardioverter defibrillator that monitors heart rhythms and automatically delivers therapy for life-threatening arrhythmias; accounts for nearly all revenue through month-to-month leases.
  • Cardiac Recovery System: Digital platform providing clinical insights and care coordination for patients at risk of sudden cardiac arrest.
  • Patient Engagement Tools: Software solutions designed to help patients follow their treatment plans and stay connected to doctors.

Recent Strategic Moves

  • Completed an initial public offering in March 2025 to fund research and commercial operations.
  • Finished a second public stock offering in December 2025, resulting in net proceeds of $149.3 million.
  • Established a strategic collaboration with Biobeat Technologies to enhance product development and data insights.
  • Secured a $200 million senior loan facility in July 2026 to support general corporate and working capital requirements.

What Makes the Tech Different

Kestra focuses on a patient-centered design that emphasizes comfort and low false alarm rates to ensure patients wear the device for extended periods. The company integrates its wearable hardware with a digital ecosystem to provide healthcare providers with continuous data and actionable clinical insights.

Financial Results at a Glance

  • Revenue was $31.0 million for the three months ended July 31, 2026, up 60% year over year.
  • Gross profit reached $17.5 million for the three months ended July 31, 2026, up 98% year over year.
  • Net loss was $44.1 million for the three months ended July 31, 2026, compared to $25.8 million for the three months ended July 31, 2025.
  • Cash, cash equivalents, and investments totaled $244.7 million as of July 31, 2026.
  • Accumulated deficit was $695.9 million as of July 31, 2026.

Company Evolution

Kestra has transitioned from a research-focused startup to a commercial-stage company scaling its wearable heart technology across the United States. Its growth relies on expanding its direct sales force and securing reimbursement from Medicare, Medicaid, and private insurance providers.

AI Generated • Sep 15, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

443

CEO

Brian Webster, MBA

Website

www.kestramedical.com/about

Headquarters

Kirkland, WA 98033, US

KMTS Financials

Key Financial Metrics (TTM)

Gross Margin

53.89%

Operating Margin

-134.48%

Net Income Margin

-140.43%

Return on Equity

-64.18%

Return on Capital

-43.97%

Return on Assets

-43.15%

Earnings Yield

-9.43%

Dividend Yield

0.00%

Payout Ratio

-0.33%

Stock Overview

Market Cap

$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

59.56M

Volume

305.55K

Avg. Volume

376.26K

Financials (TTM)

Gross Profit

$57.51M

Operating Income

-$143.52M

EBITDA

-$143.86M

Operating Cash Flow

-$87.72M

Capital Expenditure

-$35.06M

Free Cash Flow

-$122.79M

Cash & ST Invst.

$198.91M

Total Debt

$76.45M

Kestra Medical Technologies Performance Analysis

Kestra Medical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30USD 7,630,000N/A
20242024-04-30USD 27,814,000264.5%
20252025-04-30USD 59,815,000115.1%
20262026-04-30USD 95,126,00059.0%
Kestra Medical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-3116.5%
Q32026-01-318.8%
Q42026-04-3016.6%
Q12026-07-318.1%
Kestra Medical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30USD -1.75N/A
20242024-04-30USD -2.0416.3%
20252025-04-30USD -2.4620.7%
20262026-04-30USD -2.43-1.1%
Kestra Medical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-31-28.0%
Q32026-01-314.7%
Q42026-04-30-9.8%
Q12026-07-31-11.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$30.97M

+59.9%

Gross Profit

$17.50M

+97.7%

Gross Margin

56.50%

N/A

Market Cap

$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.80M

N/A

Employees

443

N/A

Net Income

-$44.09M

-70.7%

EBITDA

-$34.99M

-60.1%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$198.91M

-1.1%

Total Debt

$76.45M

+71.4%

Accounts Receivable

$15.41M

+66.6%

Inventory

$0.00

-100.0%

Long Term Debt

$76.42M

+71.5%

Short Term Debt

$23.00K

-36.1%

Return on Assets

-43.15%

N/A

Return on Invested Capital

-47.99%

N/A

Free Cash Flow

-$40.63M

-18.0%

Operating Cash Flow

-$32.30M

-22.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZTAAzenta, Inc.
$34.48-1.18%
BLFSBioLife Solutions, Inc.
$36.78-5.33%
NVCRNovocure Ltd
$15.92-0.19%
STAASTAAR Surgical Company
$22.38-1.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$13.23+4.50%
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$76.94+0.09%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$31.58-4.53%
INTCIntel
$120.22-0.01%

Questions About KMTS

What is the current price of Kestra Medical Technologies?

Kestra Medical Technologies is trading at $27.05 per share.

What is the 52-week range for Kestra Medical Technologies?

Over the past 52 weeks, Kestra Medical Technologies has traded between $17.34 and $30.00.

How much debt does Kestra Medical Technologies have?

As of the most recent reporting period, Kestra Medical Technologies reported total debt of $76.45M.

How much cash does Kestra Medical Technologies have on hand?

Kestra Medical Technologies reported $68.56M in cash and cash equivalents in its most recent financial results.

What is Kestra Medical Technologies’s dividend yield?

Kestra Medical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services